Zebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use
The nearly simultaneous convergence of human genetics and advanced molecular technologies has led to an improved understanding of human diseases. At the same time, the demand for drug screening and gene function identification has also increased, albeit time- and labor-intensive. However, bridging t...
Saved in:
Main Authors: | Hung-Chieh Lee (Author), Cheng-Yung Lin (Author), Huai-Jen Tsai (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zebrafish in Biomedical Research
Published: (2020) -
Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds
by: Wei-Chia Tseng, et al.
Published: (2018) -
An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery
by: Lee F. Willoughby, et al.
Published: (2013) -
In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish
by: Ethan Bustad, et al.
Published: (2024) -
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
by: Jie Yin, et al.
Published: (2023)